We sought to determine whether CAPON targets NO synthesis in cortical neurons. The importance of nNOS within the cell. In the present study, we identify Dexras1 as a physiologic target of nNOS is established a selective interaction of CAPON with Dexras1, a brainby the selective decrease of Dexras1 activation, but enriched member of the Ras family of small monomeric not H-Ras or four other Ras family members, in the G proteins that was recently identified in a screen for brains of mice harboring a targeted genomic deletion genes induced by dexamethasone (Kemppainen and of nNOS (nNOS Ϫ/Ϫ ). We also find that nNOS, CAPON, Behrend, 1998). We find that Dexras1, like H-Ras, is and Dexras1 form a ternary complex that enhances S-nitrosylated by NO donors and is activated by NO the ability of nNOS to activate Dexras1. These findings donors and by coexpression with nNOS. The importance identify Dexras1 as a novel physiologic NO effector of Dexras1 as a physiologic target of nNOS is estaband suggest that anchoring of nNOS to specific targets lished by its activation by NMDA receptor-stimulated is a mechanism by which NO signaling is enhanced. nNOS activity and by the finding that Dexras1 activation is diminished in the brains of mice harboring a targeted Introduction genomic deletion of nNOS (nNOS Ϫ/Ϫ ). We also find that nNOS, CAPON, and Dexras1 form a ternary complex NO serves multiple roles in biology, acting as the endothat enhances the ability of nNOS to activate Dexras1. thelial-derived relaxing factor in regulating blood vessel These data identify a novel physiologic effector of NO relaxation ( 
 Table 1 
, 1B). Additionally, we find that GST-Dexras1 is unable
GAPDH mRNA levels appeared to be much less in brain to bind to nNOS ( Figure 1B) . These results further supsamples than in heart and kidney, suggesting that, folport the notion that CAPON interacts specifically with lowing correction for RNA loading, levels of Dexras1 Dexras1.
mRNA would be enriched in brain in mice as well.
To determine if CAPON and Dexras1 interact in intact
Dexras1 contains a CAAX box, suggesting that it may cells, we conducted immunoprecipitation studies in be prenylated. We examined the membrane association brain lysates, utilizing an antibody to Dexras1 ( ing of the CA3 region ( Figure 2D ). Lower levels of Dexras1 are detected in the thalamus, diagonal band of Broca, and the substantia nigra, pars compacta. Dexras1 also occurs in the pontine nucleus, the trapezoid body, the pedunculopontine tegmental nucleus, and the nucleus solitarius (data not shown).
We next compared the distribution of Dexras1, CAPON, and nNOS mRNAs. We find these mRNAs expressed in many similar neuronal populations. The three mRNAs are coexpressed in the cortex, although in scattered cortical medium aspiny neurons nNOS is expressed at 
Dexras1 Is S-Nitrosylated by NO Donors

Ras-like G proteins alternate between an "inactive" 2000). The biotinylated proteins were bound to neutravi-GDP-bound state and an "active" GTP-bound state din agarose and then purified by cleavage of the disulthrough the action of guanine-nucleotide exchange facfide cross-linked biotin with 2-mercaptoethanol (2-ME). tors (GEFs), which enable GTP to bind by triggering the
The 2-ME eluates derived from lysates treated with GSH dissociation of GDP, and by GTPase-activating proteins, exhibit no detectable G protein, while 2-ME eluates from which increase the hydrolysis of GTP to GDP. In addition lysates treated with GSNO contain detectable amounts to these mechanisms, H-Ras can also be activated by of H-Ras and Dexras1 but not two other control G pro-S-nitrosylation, which leads to enhanced guanine-nucleoteins, Rab6 and Rap2 ( Figure 3B ). These findings inditide exchange activity and a resulting increase in the cate that Dexras1 reacts with NO donors to form nitroconcentration of active GTP-bound H-Ras ( tested whether the effect of NMDA was mediated by nNOS transfection leads to activation of Dexras1 in a nNOS using L-NAME. Pretreatment of neurons with 500 dose-dependent fashion ( Figure 4C ). nNOS transfection M L-NAME blocks NMDA-stimulated Dexras1 activahas no effect in cells that are not cotransfected with the tion, indicating that the stimulatory effect of NMDA on Myc-Dexras-expressing plasmid (data not shown). NO Dexras1 function requires NO synthesis. Thus, Dexras1 generation mediates the effect of nNOS, as the NOS activation is coupled to NMDA receptor-dependent NO inhibitor L-nitroarginine methyl ester (L-NAME) abolsynthesis. ishes Dexras1 activation, while L-arginine reverses the effects of L-NAME ( Figure 4D activation of nNOS is required for the activation of Dexras1. Immunoprecipitates using preimmune serum failed to precipitate a detectable amount of radiolabeled nucleotides (data not shown). 
CAPON Enhances nNOS Activation of Dexras1
1998). Although comparatively large amounts of NO do activate H-Ras in transfected Dexras1 is markedly enhanced by CAPON. This implies that NO signaling is regulated by protein-protein interac-HEK293 cells (M. F., S. R. J., and S. H. S., unpublished data) as well as in other cell types (Lander et al., 1995), tions that juxtapose nNOS with its targets.
One of the remarkable aspects of Dexras1 activation the failure to see differences in H-ras activation between wild-type and nNOS Ϫ/Ϫ mice may derive from the higher is the selectivity of its regulation by nNOS, as five other members of the Ras superfamily exhibited identical gualevels of NO generated in those studies. It is possible that substantial NO release, as occurs during vascular nine-nucleotide exchange activity in both wild-type and nNOS Ϫ/Ϫ mice. Importantly, H-ras, which can be regustroke, might produce sufficient NO to activate both H-Ras and Dexras1 and their respective signaling lated by iNOS in HUVEC cells (Lander et al., 1995) by NO in vivo.
Experimental Procedures
Protein Binding Assays GST fusion proteins were prepared as described previously (Jaffrey General Methods and Materials et al., 1998). Transfections were performed with 10 g or the indiMolecular biology reagents were from New England Biolabs (Bevcated quantity of each plasmid, using the calcium phosphate erly, MA). G protein antibodies were from Santa Cruz Biotechnology method. At 48 hr after transfection, cells were lysed in 1 ml lysis (Santa Cruz, CA), SNAP was from RBI (Natick, MA), and NAP was buffer C (50 mM Tris-HCl [pH 7.4], 40 mM NaCl, 1 mM EDTA, 1% from Aldrich Chem. Co. (Milwaukee, WI). All other reagents were Triton X-100, 1.5 mM NaVO 4 , 50 mM NaF, 10 mM sodium pyrophosfrom Sigma (St. Louis, MO), except as indicated.
phate, 10 mM sodium ␤-glycerophosphate, 1 mM PMSF, 5 mg/ml aprotinin, 1 mg/ml leupeptin, and 1 mg/ml pepstatin A) and cleared by centrifugation. This cellular lysate was incubated with GST fusion cDNA Cloning and Localization of Rat Dexras1 The two-hybrid screens were done as described (Jaffrey et al., 1998) .
protein immobilized on glutathione agarose for 1 hr at 4ЊC and washed four times with washing buffer (lysis buffer C plus 300 mM The PTB domain of rat CAPON, comprising amino acids 20-180, was constructed by PCR and subcloned into the SalI and NotI sites NaCl). In GST pulldown assays, HEK293 cells transfected with pCIS-GST-Dexras1 as well as the indicated plasmids were lysed in 0.5 of pPC97, encoding a GAL4 BD-CAPON-PTB fusion protein. Other control plasmids were also prepared by PCR and subcloned into ml lysis buffer C. GST agarose was incubated with clarified cell lysates for 1 hr. After incubation, the resin was washed five times SalI and NotI sites of either pPC86 or pPC97, as indicated. A total of 2 ϫ 10 6 independent clones were screened, and a positive clone with lysis buffer C adjusted to 250 mM NaCl, and bound proteins were eluted by boiling in 1ϫ SDS-PAGE sample buffer. carrying 330 bp cDNA was identified by selecting for histidine prototrophy and the presence of ␤-galactosidase activity, as described Immunoprecipitations were performed by homogenizing one rat brain in 3 ml lysis buffer B, followed by centrifugation at 100,000 ϫ previously (Jaffrey et al., 1998) counted as described above. Mice harboring a genomic deletion of nNOS have been described previously (Huang et al., 1993) and backcrossed a minimum of seven times against the C57/BL6 strain, Quantitation of Dexras1-Associated Nucleotides which was the strain used for wild-type controls. GTP loading assays were performed as previously described (Rosen et al., 1994) . In brief, HEK293 cells were washed once with phosphate-free Dulbecco's modified Eagle's medium (GIBCO-BRL) be
